Related Experiment Videos

Pheochromocytoma in Eisenmenger's syndrome: a therapeutic challenge

David Filgueiras-Rama1, J M Oliver, Jose Ruiz-Cantador

  • 1Servicio de Cardiología, Hospital Universitario Laz Paz, Madrid, Spain. davidrama12001@yahoo.es

Revista Portuguesa De Cardiologia : Orgao Oficial Da Sociedade Portuguesa De Cardiologia = Portuguese Journal of Cardiology : an Official Journal of the Portuguese Society of Cardiology
|March 25, 2011
PubMed

Insights

Minimally invasive surgery is feasible for pheochromocytoma in patients with complex congenital heart disease. This approach, combined with multidisciplinary care, offers a safe option for managing this rare but serious condition.

Area of Science:

  • Cardiology
  • Endocrinology
  • Surgical Oncology

Background:

  • Pheochromocytoma (a rare adrenal tumor) surgery carries significant hemodynamic risks.
  • These risks are amplified in patients with complex congenital heart disease, particularly cyanotic forms.
  • An increasing incidence of pheochromocytoma is noted in adults with congenital heart disease due to improved longevity.

Observation:

  • A 45-year-old woman with complex congenital heart disease and Eisenmenger's syndrome presented with pheochromocytoma.
  • The patient underwent a successful laparoscopic resection of the pheochromocytoma.
  • Management involved a multidisciplinary team approach throughout hospitalization.

Findings:

  • Laparoscopic pheochromocytoma resection is feasible in patients with complex congenital heart disease.
  • Minimally invasive surgery can be safely performed in this high-risk population.
  • Successful tumor removal was achieved with careful perioperative management.

Implications:

  • Minimally invasive surgery offers a viable and potentially safer alternative for pheochromocytoma in complex congenital heart disease patients.
  • Multidisciplinary care is crucial for optimizing outcomes in these challenging cases.
  • This case highlights the importance of considering pheochromocytoma in adults with congenital heart disease and managing it effectively.

Related Concept Videos

Barrett Esophagus-II: Clinical Manifestations and Management01:21

Barrett Esophagus-II: Clinical Manifestations and Management

Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
Adrenal Gland Disorders01:27

Adrenal Gland Disorders

Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...